Describes Pfizer’s hostile bid for Warner-Lambert in autumn 1999. Allows an evaluation of the potential synergies created and the question is whether Pfizer will pay too much.

Describes Pfizer’s hostile bid for Warner-Lambert in autumn 1999. Allows an evaluation of the potential synergies created and the question is whether Pfizer will pay too much.
«Hide

from
Stephen P. Bradley,
Matthew Sandoval
Source: Harvard Business School
14 pages.
Release Date: 11 December 2000. Prod #: 701009-PDF-ENG
Drug Wars: Pfizer’s hostile bid for Warner-Lambert in 1999 HBR case solution